CN109535525A - Macromolecule pearl cotton and preparation for vertebra fraction medicine magnetophoresis physiotherapy cushion - Google Patents

Macromolecule pearl cotton and preparation for vertebra fraction medicine magnetophoresis physiotherapy cushion Download PDF

Info

Publication number
CN109535525A
CN109535525A CN201811428349.XA CN201811428349A CN109535525A CN 109535525 A CN109535525 A CN 109535525A CN 201811428349 A CN201811428349 A CN 201811428349A CN 109535525 A CN109535525 A CN 109535525A
Authority
CN
China
Prior art keywords
vertebra
magnetophoresis
pearl cotton
physiotherapy cushion
macromolecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201811428349.XA
Other languages
Chinese (zh)
Inventor
吴国宪
王飞
王一飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Sande Medical Treatment Technology Co Ltd
Original Assignee
Guangzhou Sande Medical Treatment Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Sande Medical Treatment Technology Co Ltd filed Critical Guangzhou Sande Medical Treatment Technology Co Ltd
Priority to CN201811428349.XA priority Critical patent/CN109535525A/en
Publication of CN109535525A publication Critical patent/CN109535525A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/04Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent
    • C08J9/12Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent
    • C08J9/122Hydrogen, oxygen, CO2, nitrogen or noble gases
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2203/00Foams characterized by the expanding agent
    • C08J2203/06CO2, N2 or noble gases
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2323/00Characterised by the use of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Derivatives of such polymers
    • C08J2323/02Characterised by the use of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Derivatives of such polymers not modified by chemical after treatment
    • C08J2323/04Homopolymers or copolymers of ethene
    • C08J2323/06Polyethene
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2405/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
    • C08J2405/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K13/00Use of mixtures of ingredients not covered by one single of the preceding main groups, each of these compounds being essential
    • C08K13/02Organic and inorganic ingredients
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/18Oxygen-containing compounds, e.g. metal carbonyls
    • C08K3/24Acids; Salts thereof
    • C08K3/26Carbonates; Bicarbonates
    • C08K2003/265Calcium, strontium or barium carbonate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/30Sulfur-, selenium- or tellurium-containing compounds
    • C08K2003/3045Sulfates
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/10Esters; Ether-esters
    • C08K5/101Esters; Ether-esters of monocarboxylic acids
    • C08K5/103Esters; Ether-esters of monocarboxylic acids with polyalcohols
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/16Nitrogen-containing compounds
    • C08K5/17Amines; Quaternary ammonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)

Abstract

The invention belongs to polymeric material fields, and in particular to a kind of macromolecule pearl cotton and preparation method thereof for vertebra fraction medicine magnetophoresis physiotherapy cushion.Provided by the present invention for the macromolecule pearl cotton of vertebra fraction medicine magnetophoresis physiotherapy cushion, including following components and its weight percent: low density polyethylene (LDPE) 80.393-87.098%, foaming agent 1-2%, nucleating agent 0.5-1%, surfactant 1.4-1.6%, antistatic agent 1-3%, compound additive 9-12% and Masterbatch 0.002-0.007%.There is excellent antibacterial ability, antistatic effect provided by the present invention for the macromolecule pearl cotton of vertebra fraction medicine magnetophoresis physiotherapy cushion, have the characteristics that moisture-proof, ageing resistance is strong.

Description

Macromolecule pearl cotton and preparation for vertebra fraction medicine magnetophoresis physiotherapy cushion
Technical field
The invention belongs to polymeric material fields, and in particular to a kind of for vertebra fraction medicine magnetophoresis physiotherapy cushion Macromolecule pearl cotton and preparation method thereof.
Background technique
Vertebra fraction medicine magnetophoresis physiotherapy cushion is made of importing pad body and electromagnetic pole, and electromagnetic pole insertion imports advance capital for In vivo, importing pad body front and back material is high density PU leather, is high density moisture-proof cotton on the inside of high density PU leather, The inside for importing pad body is macromolecule pearl cotton, and electromagnetic pole is made of magnetic stainless steel electromagnetic pole and electromagnet circle.Wherein, precious Pearl cotton generally generates countless independent air bubbles through physical blowing by low density polyethylene (LDPE) rouge and constitutes, have water proof it is moisture-proof, it is shockproof, every Sound, many advantages, such as heat preservation, plasticity is good, toughness is strong, reconstituted circularly, strong crashworthiness power.
Chinese patent application CN106046512A discloses a kind of environment-friendly type pearl cotton, the ingredient including following parts by weight: 30-60 parts of resin particle;12-22 parts of foaming agent;8-12 parts of antishrinking agent;15-26 parts of Masterbatch;12-18 parts of talcum powder;Nano oxygen Change aluminium 5-8 parts;10 parts of antistatic master granule.
Chinese patent application CN103881219A discloses a kind of fragrant pearl cotton, raw material include: molecule distillating monoglyceride, Low density polyethylene (LDPE) rouge and essence oil from plant, the fragrance pearl cotton is made after being mixed by above-mentioned raw materials through physical blowing, described Molecule distillating monoglyceride accounts for 3%~5% in fragrant pearl cotton, and the low density polyethylene (LDPE) rouge is in virtue 92%~94% is accounted in fragrant pearl cotton, essence oil from plant weight shared in fragrant pearl cotton Percentage is 1%~3%.
Currently, for the macromolecule pearl cotton of vertebra fraction medicine magnetophoresis physiotherapy cushion, there are antibacterial ability differences etc. to ask Topic.
Summary of the invention
In view of the deficiencies of the prior art, the purpose of the present invention is to provide one kind manages for vertebra fraction medicine magnetophoresis Treat the macromolecule pearl cotton and preparation method thereof of pad.Provided by the present invention for the height of vertebra fraction medicine magnetophoresis physiotherapy cushion Molecule pearl cotton has excellent antibacterial ability, antistatic effect, has the characteristics that moisture-proof, ageing resistance is strong.
The technical scheme is that
A kind of macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion, including following components and its weight Percentage:
Low density polyethylene (LDPE) 80.393-87.098%, foaming agent 1-2%, nucleating agent 0.5-1%, surfactant 1.4- 1.6%, antistatic agent 1-3%, compound additive 9-12% and Masterbatch 0.002-0.007%.
Further, the macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion, including with the following group Point and its weight percent:
Low density polyethylene (LDPE) 83.695%, foaming agent 1.6%, nucleating agent 0.8%, surfactant 1.5%, antistatic agent 2.4%, compound additive 10% and Masterbatch 0.005%.
Further, the foaming agent is carbon dioxide;The surfactant is monoglyceride;The antistatic agent is second Oxygroup alkylamine.
Further, the nucleating agent is made of calcium carbonate and calcium sulfate by weight 5-8: 1-4.
Further, the nucleating agent is made of calcium carbonate and calcium sulfate by weight 7: 3.
Further, the compound additive is prepared by the raw material of following weight proportion: pearl powder 8-10, chitosan oligosaccharide 3-5, bamboo charcoal powder 1-3 and polylactic acid 4-6.
Further, the compound additive is prepared by the raw material of following weight proportion: pearl powder 9, chitosan oligosaccharide 4, bamboo charcoal powder 2 and polylactic acid 5.
Further, the compound additive the preparation method comprises the following steps: chitosan oligosaccharide and polylactic acid are mixed, be ground to 80-120 Mesh obtains fine powder, and above-mentioned fine powder is added in reaction kettle, and pearl powder and bamboo charcoal powder are added into aforesaid reaction vessel, is heated to 90- 110 DEG C, stirred under the revolving speed of 700-1000r/min, be blended 2-4h to get.
Further, 110 mesh are ground in the preparation method of the compound additive.
Further, 105 DEG C are heated in the preparation method of the compound additive, are stirred under the revolving speed of 850r/min It mixes, 3h is blended.
The preparation method of macromolecule pearl cotton of the present invention for vertebra fraction medicine magnetophoresis physiotherapy cushion, packet Include following steps:
S1 puts into low density polyethylene (LDPE), nucleating agent, antistatic agent, compound additive and Masterbatch in extruder, rises Temperature is to 110-120 DEG C, the melt blending under the revolving speed of 550-750r/min, and the blending time is 18-30min, respectively by foaming agent It is injected into above-mentioned extruder with surfactant, is uniformly mixed, obtains mixing material;
S2 will be kneaded material extrusion molding obtained by step S1, cooling, traction, flattening, wind to get.
Further, the step S1 is warming up to 116 DEG C, the melt blending under the revolving speed of 680r/min, be blended the time be 24min。
Antibacterial tests discovery through the macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion, system of the present invention The standby macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion to the antibiotic rate of bacillus subtilis >= 98.8%, to antibiotic rate >=97.6% of Escherichia coli, to antibiotic rate >=97.8% of Candida albicans, to Staphylococcus aureus Antibiotic rate >=97.9% of bacterium.It can be seen that the high score prepared by the present invention for vertebra fraction medicine magnetophoresis physiotherapy cushion Sub- pearl cotton all has significant antibacterial to bacillus subtilis, Escherichia coli, Candida albicans and staphylococcus aureus and imitates Fruit.Illustrate simultaneously, the present invention compound is added by pearl powder, chitosan oligosaccharide, bamboo charcoal powder and polylactic acid as what constant weight percentage formed Add agent, mutually cooperateed with other raw materials in the present invention, plays a part of to enhance antibacterial ability.
Antistatic test discovery through the macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion, the present invention Resistivity≤4.3M Ω m of the macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion of preparation, hence it is evident that low In the resistivity of the macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion prepared by comparative example 1 and comparative example 2. It can be seen that the macromolecule pearl cotton prepared by the present invention for vertebra fraction medicine magnetophoresis physiotherapy cushion has significant resist Electrostatic efficiency.This explanation, the present invention in antistatic agent and the present invention in other compositions, if compound additive mutually cooperates with, Play a part of to enhance antistatic effect.
The present invention is used for the macromolecule pearl cotton of vertebra fraction medicine magnetophoresis physiotherapy cushion by low density polyethylene (LDPE), foaming The raw materials such as agent, nucleating agent and compound additive are prepared.Wherein the compound additive is by pearl powder, chitosan oligosaccharide, bamboo charcoal powder It is prepared with polylactic acid.It interacts, makes between the ingredients such as the antistatic agent in compound additive and the present invention in the present invention The product being prepared has many advantages, such as good antibacterial ability and antistatic effect.
Compared with prior art, provided by the present invention for the macromolecule pearl of vertebra fraction medicine magnetophoresis physiotherapy cushion Cotton has the advantage that
(1) have provided by the present invention for the macromolecule pearl cotton of vertebra fraction medicine magnetophoresis physiotherapy cushion excellent Antibacterial ability, antistatic effect have the characteristics that moisture-proof, ageing resistance is strong.
(2) safety is used not provided by the present invention for the macromolecule pearl cotton of vertebra fraction medicine magnetophoresis physiotherapy cushion Inflammable foaming agent, and it is added to antistatic agent and compound additive, keep the product safety coefficient being prepared high.
(3) high provided by the present invention for the macromolecule pearl cotton feature of environmental protection of vertebra fraction medicine magnetophoresis physiotherapy cushion.
(4) provided by the present invention for the macromolecule pearl cotton function admirable of vertebra fraction medicine magnetophoresis physiotherapy cushion, Meanwhile there is good cold resistance and heat resistance.
Specific embodiment
The following describes the present invention further through the description of specific embodiments, but it is to limit of the invention that this, which is not, System, those skilled in the art's basic thought according to the present invention can make various modifications or improvements, but without departing from this The basic thought of invention, is all within the scope of the present invention.
Pearl powder of the present invention is purchased from lake under Zhuji City mountain and engraves into pearl firm, article No. F03;Chitosan oligosaccharide is purchased from Wuhan thousand Moisten bioengineering Co., Ltd, model 0222;Bamboo charcoal powder is purchased from Zhejiang Wang Lin Biotechnology Co., Ltd, model WL- BCB01;Polylactic acid is purchased from Suzhou Le Le plastic material Co., Ltd, trade mark 6201D;Masterbatch is purchased from Qingdao letter and contains plastic cement Science and Technology Ltd., brand letter are contained.
Embodiment 1, a kind of macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion
The macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion, including following components and its weight Percentage:
Low density polyethylene (LDPE) 87.098%, foaming agent 1%, nucleating agent 0.5%, surfactant 1.4%, antistatic agent 1%, compound additive 9% and Masterbatch 0.002%.
The foaming agent is carbon dioxide;The surfactant is monoglyceride;The antistatic agent is ethoxylation alkane Base amine.
The nucleating agent is made of calcium carbonate and calcium sulfate by weight 5: 4.
The compound additive is prepared by the raw material of following weight proportion: pearl powder 8, chitosan oligosaccharide 3,1 He of bamboo charcoal powder Polylactic acid 4.
The compound additive the preparation method comprises the following steps: chitosan oligosaccharide and polylactic acid are mixed, be ground to 80 mesh, obtain fine powder, will Above-mentioned fine powder is added in reaction kettle, and pearl powder and bamboo charcoal powder are added into aforesaid reaction vessel, 90 DEG C are heated to, 700r/min's Stirred under revolving speed, be blended 2h to get.
The preparation method of the macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion, including following step It is rapid:
S1 puts into low density polyethylene (LDPE), nucleating agent, antistatic agent, compound additive and Masterbatch in extruder, rises Temperature is to 110 DEG C, the melt blending under the revolving speed of 550r/min, and the blending time is 18min, respectively by foaming agent and surfactant It is injected into above-mentioned extruder, is uniformly mixed, obtains mixing material;
S2 will be kneaded material extrusion molding obtained by step S1, cooling, traction, flattening, wind to get.
Embodiment 2, a kind of macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion
The macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion, including following components and its weight Percentage:
Low density polyethylene (LDPE) 80.393%, foaming agent 2%, nucleating agent 1%, surfactant 1.6%, antistatic agent 3%, Compound additive 12% and Masterbatch 0.007%.
The foaming agent is carbon dioxide;The surfactant is monoglyceride;The antistatic agent is ethoxylation alkane Base amine.
The nucleating agent is made of calcium carbonate and calcium sulfate by weight 8: 1.
The compound additive is prepared by the raw material of following weight proportion: pearl powder 10, chitosan oligosaccharide 5,3 He of bamboo charcoal powder Polylactic acid 6.
The compound additive the preparation method comprises the following steps: chitosan oligosaccharide and polylactic acid are mixed, be ground to 120 mesh, obtain fine powder, will Above-mentioned fine powder is added in reaction kettle, and pearl powder and bamboo charcoal powder are added into aforesaid reaction vessel, 110 DEG C are heated to, in 1000r/min Revolving speed under stir, be blended 4h to get.
The preparation method of the macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion, including following step It is rapid:
S1 puts into low density polyethylene (LDPE), nucleating agent, antistatic agent, compound additive and Masterbatch in extruder, rises Temperature is to 120 DEG C, the melt blending under the revolving speed of 750r/min, and the blending time is 30min, respectively by foaming agent and surfactant It is injected into above-mentioned extruder, is uniformly mixed, obtains mixing material;
S2 will be kneaded material extrusion molding obtained by step S1, cooling, traction, flattening, wind to get.
Embodiment 3, a kind of macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion
The macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion, including following components and its weight Percentage:
Low density polyethylene (LDPE) 83.695%, foaming agent 1.6%, nucleating agent 0.8%, surfactant 1.5%, antistatic agent 2.4%, compound additive 10% and Masterbatch 0.005%.
The foaming agent is carbon dioxide;The surfactant is monoglyceride;The antistatic agent is ethoxylation alkane Base amine.
The nucleating agent is made of calcium carbonate and calcium sulfate by weight 7: 3.
The compound additive is prepared by the raw material of following weight proportion: pearl powder 9, chitosan oligosaccharide 4,2 He of bamboo charcoal powder Polylactic acid 5.
The compound additive the preparation method comprises the following steps: chitosan oligosaccharide and polylactic acid are mixed, be ground to 110 mesh, obtain fine powder, will Above-mentioned fine powder is added in reaction kettle, and pearl powder and bamboo charcoal powder are added into aforesaid reaction vessel, 105 DEG C are heated to, in 850r/min Revolving speed under stir, be blended 3h to get.
The preparation method of the macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion, including following step It is rapid:
S1 puts into low density polyethylene (LDPE), nucleating agent, antistatic agent, compound additive and Masterbatch in extruder, rises Temperature is to 116 DEG C, the melt blending under the revolving speed of 680r/min, and the blending time is 24min, respectively by foaming agent and surfactant It is injected into above-mentioned extruder, is uniformly mixed, obtains mixing material;
S2 will be kneaded material extrusion molding obtained by step S1, cooling, traction, flattening, wind to get.
Comparative example 1, a kind of macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion
The macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion, including following components and its weight Percentage:
Low density polyethylene (LDPE) 83.695%, foaming agent 1.6%, nucleating agent 0.8%, surfactant 1.5%, antistatic agent 2.4%, compound additive 10% and Masterbatch 0.005%.
The foaming agent is carbon dioxide;The surfactant is monoglyceride;The antistatic agent is ethoxylation alkane Base amine.
The nucleating agent is made of calcium carbonate and calcium sulfate by weight 7: 3.
The compound additive is prepared by the raw material of following weight proportion: pearl powder 11, bamboo charcoal powder 3 and polylactic acid 6.
The compound additive the preparation method comprises the following steps: polylactic acid is ground to 110 mesh, obtain fine powder, above-mentioned fine powder be added In reaction kettles, pearl powder and bamboo charcoal powder are added into aforesaid reaction vessel, is heated to 105 DEG C, is stirred under the revolving speed of 850r/min, Be blended 3h to get.
The preparation method and 3 class of embodiment of the macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion Seemingly.
As different from Example 3, the compound additive is prepared by the raw material of following weight proportion: pearl powder 11, bamboo charcoal powder 3 and polylactic acid 6.
Comparative example 2, a kind of macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion
The macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion, including following components and its weight Percentage:
Low density polyethylene (LDPE) 83.695%, foaming agent 1.6%, nucleating agent 0.8%, surfactant 1.5%, antistatic agent 2.4%, compound additive 10% and Masterbatch 0.005%.
The foaming agent is carbon dioxide;The surfactant is monoglyceride;The antistatic agent is ethoxylation alkane Base amine.
The nucleating agent is made of calcium carbonate and calcium sulfate by weight 7: 3.
The compound additive is prepared by the raw material of following weight proportion: pearl powder 9, chitosan 4,2 He of bamboo charcoal powder Polylactic acid 5.
The compound additive the preparation method comprises the following steps: chitosan and polylactic acid are mixed, be ground to 110 mesh, obtain fine powder, will Above-mentioned fine powder is added in reaction kettle, and pearl powder and bamboo charcoal powder are added into aforesaid reaction vessel, 105 DEG C are heated to, in 850r/min Revolving speed under stir, be blended 3h to get.
The preparation method and embodiment 3 of the macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion It is similar.
As different from Example 3, the compound additive is prepared by the raw material of following weight proportion: pearl powder 9, Chitosan 4, bamboo charcoal powder 2 and polylactic acid 5.
Test example one, for vertebra fraction medicine magnetophoresis physiotherapy cushion macromolecule pearl cotton performance detection test
1, test material: prepared by embodiment 1, embodiment 2, embodiment 3, comparative example 1 and comparative example 2 is used for vertebra position Electric medicament magnetic conductance enters the macromolecule pearl cotton of physiotherapy cushion.
2, test method: referring to the related mark such as GB/T 6669 " measurement of flexible foam polymeric material compression set " Standard, to being managed for vertebra fraction medicine magnetophoresis for embodiment 1, embodiment 2, embodiment 3, comparative example 1 and comparative example 2 preparation The macromolecule pearl cotton for treating pad carries out tearing strength, tensile strength, compressive strength, compression set rate, cold resistance, heat resistance Detection.
3, test result
Test result is as shown in table 1.
Table 1: the performance test results of the macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion
As can be seen from Table 1, the macromolecule pearl prepared by the present invention for vertebra fraction medicine magnetophoresis physiotherapy cushion Tearing strength, tensile strength and the compressive strength of cotton, be above prepared by comparative example 1 and comparative example 2 for vertebra position medicine The macromolecule pearl cotton of object magnetophoresis physiotherapy cushion, and what compression set rate was prepared significantly lower than comparative example 1 and comparative example 2 Macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion.This explanation, it is prepared by the present invention to be used for vertebra position Electric medicament magnetic conductance enters the function admirable of the macromolecule pearl cotton of physiotherapy cushion, meanwhile, there is good cold resistance and heat resistance.
Test example two, for vertebra fraction medicine magnetophoresis physiotherapy cushion macromolecule pearl cotton antibacterial tests
1, test material: prepared by embodiment 1, embodiment 2, embodiment 3, comparative example 1 and comparative example 2 is used for vertebra position Electric medicament magnetic conductance enters the macromolecule pearl cotton of physiotherapy cushion.
2, test method:
Vertebra fraction medicine electromagnetism is used for by prepared by embodiment 1, embodiment 2, embodiment 3, comparative example 1 and comparative example 2 50mm × 50mm specification is made in the macromolecule pearl cotton for importing physiotherapy cushion, referring to QB/T 2591-2003, is detected with film applicator coating anti- Bacterium performance, the antibiotic rate after investigating sample for 24 hours;Referring to GB/T 4789.2, total plate count is measured.Antibiotic rate calculates as follows:
R (%)=(B-C)/B × 100
In formula: R is antibiotic rate, %;B is that blank control sample is averaged bacterial count recovered, cfu/ piece;C is test material sample Average bacterial count recovered, cfu/ piece.
3, test result:
Test result is as shown in table 2.
Table 2: the antibacterial tests result of the macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion
As can be seen from Table 2, the macromolecule pearl prepared by the present invention for vertebra fraction medicine magnetophoresis physiotherapy cushion Cotton is apparently higher than 1 and of comparative example to the antibiotic rate of bacillus subtilis, Escherichia coli, Candida albicans and staphylococcus aureus Macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion prepared by comparative example 2.It can be seen that prepared by the present invention The macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion to bacillus subtilis, Escherichia coli, white read Pearl bacterium and staphylococcus aureus all have significant antibacterial effect.
Test example three, for vertebra fraction medicine magnetophoresis physiotherapy cushion macromolecule pearl cotton antistatic test
1, test material: prepared by embodiment 1, embodiment 2, embodiment 3, comparative example 1 and comparative example 2 is used for vertebra position Electric medicament magnetic conductance enters the macromolecule pearl cotton of physiotherapy cushion.
2, test method:
It is prepared referring to GB/T 1410-1989 testing example 1, embodiment 2, embodiment 3, comparative example 1 and comparative example 2 The resistivity of macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion.
3, test result:
Test result is as shown in table 3.
Table 3: the antistatic test result of the macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion
As can be seen from Table 3, the macromolecule pearl prepared by the present invention for vertebra fraction medicine magnetophoresis physiotherapy cushion The resistivity of cotton is respectively 4.1M Ω m, 3.6M Ω m, 3.2M Ω m, and prepared by comparative example 1 and comparative example 2 is used for ridge The resistivity of the macromolecule pearl cotton of vertebra fraction medicine magnetophoresis physiotherapy cushion is respectively 15.2M Ω m, 18.6M Ω m.By This is as it can be seen that the macromolecule pearl cotton prepared by the present invention for vertebra fraction medicine magnetophoresis physiotherapy cushion is quiet with significantly resisting Electric effect.

Claims (10)

1. a kind of macromolecule pearl cotton for vertebra fraction medicine magnetophoresis physiotherapy cushion, which is characterized in that including with the following group Point and its weight percent:
Low density polyethylene (LDPE) 80.393-87.098%, foaming agent 1-2%, nucleating agent 0.5-1%, surfactant 1.4- 1.6%, antistatic agent 1-3%, compound additive 9-12% and Masterbatch 0.002-0.007%.
2. being used for the macromolecule pearl cotton of vertebra fraction medicine magnetophoresis physiotherapy cushion as described in claim 1, feature exists In, including following components and its weight percent:
Low density polyethylene (LDPE) 83.695%, foaming agent 1.6%, nucleating agent 0.8%, surfactant 1.5%, antistatic agent 2.4%, compound additive 10% and Masterbatch 0.005%.
3. being used for the macromolecule pearl cotton of vertebra fraction medicine magnetophoresis physiotherapy cushion, feature as claimed in claim 1 or 2 It is, the foaming agent is carbon dioxide;The surfactant is monoglyceride;The antistatic agent is ethoxylated alkyl Amine.
4. being used for the macromolecule pearl cotton of vertebra fraction medicine magnetophoresis physiotherapy cushion, feature as claimed in claim 1 or 2 It is, the nucleating agent is made of calcium carbonate and calcium sulfate by weight 5-8: 1-4.
5. being used for the macromolecule pearl cotton of vertebra fraction medicine magnetophoresis physiotherapy cushion, feature as claimed in claim 1 or 2 It is, the compound additive is prepared by the raw material of following weight proportion: pearl powder 8-10, chitosan oligosaccharide 3-5, bamboo charcoal powder 1- 3 and polylactic acid 4-6.
6. being used for the macromolecule pearl cotton of vertebra fraction medicine magnetophoresis physiotherapy cushion as claimed in claim 5, feature exists In the compound additive is prepared by the raw material of following weight proportion: pearl powder 9, chitosan oligosaccharide 4, bamboo charcoal powder 2 and polylactic acid 5。
7. being used for the macromolecule pearl cotton of vertebra fraction medicine magnetophoresis physiotherapy cushion as claimed in claim 5, feature exists In, the compound additive the preparation method comprises the following steps: chitosan oligosaccharide and polylactic acid are mixed, it is ground to 80-120 mesh, obtains fine powder, it will be upper It states fine powder to be added in reaction kettle, pearl powder and bamboo charcoal powder is added into aforesaid reaction vessel, 90-110 DEG C is heated to, in 700- Stirred under the revolving speed of 1000r/min, be blended 2-4h to get.
8. being used for the macromolecule pearl cotton of vertebra fraction medicine magnetophoresis physiotherapy cushion as claimed in claim 7, feature exists In, it is heated to 105 DEG C in the preparation method of the compound additive, is stirred under the revolving speed of 850r/min, blending 3h.
9. such as the described in any item macromolecule pearl cottons for vertebra fraction medicine magnetophoresis physiotherapy cushion of claim 1-8 Preparation method, which comprises the following steps:
S1 puts into low density polyethylene (LDPE), nucleating agent, antistatic agent, compound additive and Masterbatch in extruder, is warming up to 110-120 DEG C, the melt blending under the revolving speed of 550-750r/min, the blending time is 18-30min, respectively by foaming agent and table Face activating agent is injected into above-mentioned extruder, is uniformly mixed, is obtained mixing material;
S2 will be kneaded material extrusion molding obtained by step S1, cooling, traction, flattening, wind to get.
10. the preparation side for the macromolecule pearl cotton of vertebra fraction medicine magnetophoresis physiotherapy cushion as claimed in claim 9 Method, which is characterized in that the step S1 is warming up to 116 DEG C, the melt blending under the revolving speed of 680r/min, be blended the time be 24min。
CN201811428349.XA 2018-11-27 2018-11-27 Macromolecule pearl cotton and preparation for vertebra fraction medicine magnetophoresis physiotherapy cushion Withdrawn CN109535525A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811428349.XA CN109535525A (en) 2018-11-27 2018-11-27 Macromolecule pearl cotton and preparation for vertebra fraction medicine magnetophoresis physiotherapy cushion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811428349.XA CN109535525A (en) 2018-11-27 2018-11-27 Macromolecule pearl cotton and preparation for vertebra fraction medicine magnetophoresis physiotherapy cushion

Publications (1)

Publication Number Publication Date
CN109535525A true CN109535525A (en) 2019-03-29

Family

ID=65851630

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811428349.XA Withdrawn CN109535525A (en) 2018-11-27 2018-11-27 Macromolecule pearl cotton and preparation for vertebra fraction medicine magnetophoresis physiotherapy cushion

Country Status (1)

Country Link
CN (1) CN109535525A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111621075A (en) * 2020-06-11 2020-09-04 合肥市兴烨包装材料有限公司 Preparation method of pearl cotton particles for pillow inner material

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111621075A (en) * 2020-06-11 2020-09-04 合肥市兴烨包装材料有限公司 Preparation method of pearl cotton particles for pillow inner material

Similar Documents

Publication Publication Date Title
CN106221165B (en) A kind of whole life cycle design of high-barrier and preparation method thereof
CN102558651B (en) Antibacterial flavoring master batch
CN101205329B (en) High-effectively antibiotic polypropylene master batch and preparation thereof
CN107207825B (en) Thermoplastic resin composition and mechanograph comprising the thermoplastic resin composition
CN104072955B (en) A kind of antibacterial polylactic acid composite and preparation method thereof
CN112679928A (en) Full-biodegradable antibacterial PLA/PBAT film and preparation method thereof
CN103408861B (en) A kind of plastic floor base material and preparation method thereof
KR102306427B1 (en) Polylactic acid composite material and its application
CN107312228A (en) It is a kind of for antibacterial matrices of vinyon and preparation method thereof
CN102125054A (en) Antibacterial composition, antibacterial product and antibacterial method
CN102838809A (en) Antibacterial polypropylene plastic and preparation method thereof
CN109535525A (en) Macromolecule pearl cotton and preparation for vertebra fraction medicine magnetophoresis physiotherapy cushion
CN111825920A (en) Stress whitening-resistant antibacterial polypropylene composition and preparation method thereof
CN102827447A (en) Antimicrobial HIPS (high impact polystyrene) plastic and preparation method thereof
CN113045879B (en) High-tear-resistance PLA-PBAT composite degradable resin and preparation method and application thereof
CN111100403A (en) PVC wood-plastic foaming antibacterial plate and preparation method thereof
CN108610551A (en) A kind of anti-microbial plastic composition and anti-biotic material and preparation method and application
CN109401023A (en) HDPE antibiotic plastic and preparation method thereof
CN105418972A (en) Organic antimicrobial agent intercalation modified montmorillonite and application thereof
CN108329612A (en) A kind of nontoxic polystyrene material of permanent antibacterial and mouldproof and preparation method thereof
CN109705573B (en) Guanidine salt composite antibacterial agent and preparation method thereof
CN109467894A (en) A kind of antibacterial matrices and preparation method thereof for Tritan copolyester
CN106147157A (en) Lactic acid composite material and products thereof
CN113248860A (en) Antibacterial universal plastic material and preparation method thereof
CN103881254B (en) A kind of Friction resistance plastic

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20190329